Intermountain Health spinoff Culmination Bio has announced a partnership with BillionToOne on oncology diagnostics. BillionToOne leverages Culmination Bio's data lake and patient recruitment ...

Merck & Co. signed a R&D collaboration deal with data and technology provider Culmination Bio, a recent spinoff from Intermountain Health. Under the deal, Merck gets access to Culmination’s clinical ...

Drug development is a lengthy and costly process, taking over ten years and costing over $1 billion. That’s because, currently, there’s no efficient process to bring a drug or diagnostic to market.

Cancer is on the rise worldwide: according to the World Health Organization, there will be over 35 million new cancer cases in 2050, a 77% increase from the estimated 20 million cases in 2022. Luckily ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...